Showing results (3401-3410 of 9,444) with videos related to

Sort By:
Pageof 945
Clinical Endocrinology|December 1, 1993
Recombinant human growth hormone therapy does not increase microalbuminuria in children with short statureD Levine, P Kreitzer, S Freedman, et al.
Clinical Endocrinology|December 1, 1993
Hypercalcaemia due to parathyroid hormone-related protein: long-term circulating levels may not reflect tumour activityM W Savage, W D Fraser, C W Bodmer, et al.
Clinical Endocrinology|June 1, 1996
Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studiesB C Tanis, G J Westendorp, H M Smelt
Clinical Endocrinology|June 1, 1996
Three years of GH treatment in Turner's syndrome: complex effect of GH dosage on growth parameters. French Pediatric Clinics and Sanofi-WinthropA M Bertrand, J L Chaussain, B Job, et al.
Clinical Endocrinology|June 1, 1996
Predicting the growth response to growth hormone in patients with intrauterine growth retardationG R Frank, P T Cheung, J A Horn, et al.
Clinical Endocrinology|June 1, 1996
Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndromeP Contreras, V Araya
Clinical Endocrinology|June 1, 1996
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapyS G Soule, J Farhi, G S Conway, et al.
Clinical Endocrinology|June 1, 1996
An ovarian lipid cell tumour causing virilization and Cushing's syndromeT A Elhadd, V Connolly, D Cruickshank, et al.
Clinical Endocrinology|May 1, 1996
Bone mass and metabolism in women aged 45-55M Garton, J Martin, S New, et al.
Clinical Endocrinology|May 1, 1996
The GnRH challenge test: a quantitative measure of pituitary desensitization during GnRH agonist administrationF Scheele, P G Hompes, C B Lambalk, et al.
Pageof 945